Tag: Clinical research
IIT Guwahati researchers pioneer adaptive multi-stage clinical trial method for personalized...
The research aims to enhance patient-specific treatment plans, improve outcomes, reduce trial-and-error in medication, and foster a more efficient, personalised healthcare approach
Veeda Group rebrands as Veeda Lifesciences
Veeda Lifesciences represents the brand that integrates Veeda Clinical Research, Health Data Specialists, and Bioneeds India
“There is a growing trend towards outsourcing clinical trials to India”
Dr Mahesh Bhalgat, Managing Director & Group CEO, Veeda Clinical Research Limited shares his vision for the company, latest developments, long-term growth, industry trends and future outlook
Parexel names Keri Mattox as Chief Business Officer
Healthcare executive to lead company’s business operations and growth strategy
Akums Drugs secures patent for room temperature stable oral suspension of...
This development offers a significant advance in addressing the storage and accessibility challenges associated with Hydroxyurea solution
Parexel expands real-world research capabilities with new leadership
Mike D’Ambrosio appointed as Senior Vice President, Global Head of Real World Research, to enhance evidence-based approaches
Fujitsu tackles ‘drug loss’ in Japan through ecosystem to accelerate digitalization...
Fujitsu forms strategic partnership with Paradigm and will provide offerings that leverage the power of AI
Parexel’s greenhouse gas reduction targets achieve SBTi validation
Global clinical research leader receives validation for environmental targets, pledging 42% emission cuts and 100% renewable energy by 2030
Expecto Health Science appoints Dr Pramod Kashid as its new CEO
Dr Kashid joins Expecto Health Science’s leadership team to drive clinical research innovations in emerging economies
Parexel releases 2023 ESG report, targets net-zero by 2050
In 2024, Parexel submitted science-based emission reduction targets for validation with the Science Based Target initiative (SBTi), setting a pathway to achieve net-zero value chain greenhouse gas (GHG) emissions (Scopes 1, 2, and 3) by 2050.